Catalyst Pharma's total assets for Q4 2025 were $1.11B, an increase of 5.25% from the previous quarter. CPRX total liabilities were $152.54M for the fiscal quarter, a 16.13% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.